John R Wingard, M.D.
Professor Emeritus, Former Deputy Director of UF Health Cancer Center, and Former Director of Bone Marrow Transplant Program
About John R Wingard
Dr. Wingard was a professor of medicine within the division of hematology and oncology and served as Price Eminent Scholar, Director of the Blood and Marrow Transplant and Cellular Therapy Program and Hematologic Malignancy Service. He is also a former Deputy Director of the UF Health Cancer Center. Dr. Wingard retired in 2023 and is now professor emeritus in the division of hematology and oncology.
Dr. Wingard has been continuously NIH-funded since 1999. He has published more than 400 articles in peer-reviewed journals, more than 60 book chapters, and has edited 4 books. Dr. Wingard has been honored twice by being selected for the University of Florida Research Foundation Professorship, which recognizes faculty members who have distinguished records of research. In 2018 and 2019, he was named a Highly Cited Researcher by Clarivate Analytics (top 1% most-cited reports in one’s field during the year of publication).
Dr. Wingard has held a number of leadership positions in the field of cellular therapy, including current Chair of the Advisory Committee of the Center for International Blood and Marrow Transplant Research, Chair of the Steering Committee of the NHLBI/NCI Blood and Marrow Transplant Clinical Trials Network, member of the Board of Directors of the Foundation for the Accreditation of Cellular Therapies, Past President of the American Society of Blood and Marrow Transplantation, and past Chair of the National Marrow Donor Program Board of Directors.
Accomplishments
Highly Cited Researcher
2019
·
Clarivate Analytics
Highly Cited Researcher
2018
·
Clarivate Analytics
Teaching Profile
Courses Taught
2018
MDC7203 Senior Medicine Clerk
2018
MDC7200 Medicine Clerkship
2018
GMS6009 Principles of Drug Action and Therapeutics
2018
BMS6300 Fund Micro and Immuno
2017
GMS6847 Translational Research and Therapeutics: Bench, Bedside, Community, & Policy
2015
GMS6845 Clinical & Translational Research Practicum
Board Certifications
-
Internal MedicineAmerican Board of Internal Medicine
-
OncologyAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Cancer
- Hematology and Oncology
Areas of Interest
- Acute myeloid leukemia (AML) – children
- Bone marrow transplant
- Cancer treatment information
- Leukemia
- Multiple myeloma
- Myelodysplastic Syndromes (MDS)
- Non-Hodgkin lymphoma
- Stem cell research
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-7478-5398
Publications
Academic Articles
2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
Blood.
[DOI] 10.1182/blood.2024025154.
[PMID] 39775763.
2024
A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[DOI] 10.1002/ncp.11264.
[PMID] 39704085.
2024
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia.
Leukemia & lymphoma.
65(10):1502-1510
[DOI] 10.1080/10428194.2024.2361111.
[PMID] 38841781.
2024
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.
Stem cells translational medicine.
13(2):125-136
[DOI] 10.1093/stcltm/szad080.
[PMID] 38071749.
2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Blood advances.
8(16):4281-4293
[DOI] 10.1182/bloodadvances.2024013451.
[PMID] 38916866.
2024
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
42(15):1766-1775
[DOI] 10.1200/JCO.23.02474.
[PMID] 38471061.
2024
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
Transplantation and Cellular Therapy.
30(1):114.e1-114.e16
[DOI] 10.1016/j.jtct.2023.09.017.
[PMID] 37775070.
2024
Post-transplantation cyclophosphamide is associated with increased bacterial infections.
Bone marrow transplantation.
59(1):76-84
[DOI] 10.1038/s41409-023-02131-z.
[PMID] 37903992.
2024
Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis.
Blood advances.
8(18):4963-4976
[DOI] 10.1182/bloodadvances.2024013074.
[PMID] 38776400.
2024
Vaccines: a promising therapy for myelodysplastic syndrome.
Journal of hematology & oncology.
17(1)
[DOI] 10.1186/s13045-023-01523-4.
[PMID] 38191498.
2023
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology
Transplantation and Cellular Therapy.
29(1):10-18
[DOI] 10.1016/j.jtct.2022.10.010.
[PMID] 36273782.
2023
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors
Transplantation and Cellular Therapy.
29(3):202.e1-202.e8
[DOI] 10.1016/j.jtct.2022.11.016.
[PMID] 36427784.
2023
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Transplantation and cellular therapy.
29(6):388.e1-388.e6
[DOI] 10.1016/j.jtct.2023.02.011.
[PMID] 36870388.
2023
Physical Activity Compliance to American Cancer Society Recommendations Amongst Hematopoietic Stem Cell Transplant Survivors.
Hematology/oncology and stem cell therapy.
16(4):358-365
[DOI] 10.56875/2589-0646.1037.
[PMID] 37363980.
2023
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
Transplantation and cellular therapy.
29(11):709.e1-709.e11
[DOI] 10.1016/j.jtct.2023.07.013.
[PMID] 37482244.
2023
Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma.
Clinical lymphoma, myeloma & leukemia.
23(10):719-732
[DOI] 10.1016/j.clml.2023.05.008.
[PMID] 37353432.
2023
Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study.
Cancers.
15(15)
[DOI] 10.3390/cancers15153941.
[PMID] 37568757.
2022
Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy.
28(10):701.e1-701.e7
[DOI] 10.1016/j.jtct.2022.07.018.
[PMID] 35872304.
2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.
The Lancet. Haematology.
9(5):e374-e384
[DOI] 10.1016/S2352-3026(22)00045-X.
[PMID] 35483398.
2022
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors
Transplantation and Cellular Therapy.
28(9):606.e1-606.e8
[DOI] 10.1016/j.jtct.2022.05.035.
[PMID] 35662590.
2022
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor’s Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.
Transplantation and cellular therapy.
28(9):603.e1-603.e7
[DOI] 10.1016/j.jtct.2022.05.042.
[PMID] 35688325.
2021
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies.
Transplantation and cellular therapy.
27(10):837.e1-837.e10
[DOI] 10.1016/j.jtct.2021.06.028.
[PMID] 34224914.
2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients.
EClinicalMedicine.
33
[DOI] 10.1016/j.eclinm.2021.100787.
[PMID] 33842870.
2021
Aspergillus Polymerase Chain Reaction-An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal Disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
72(Suppl 2):S95-S101
[DOI] 10.1093/cid/ciaa1865.
[PMID] 33709129.
2021
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis.
Bone marrow transplantation.
56(2)
[DOI] 10.1038/s41409-020-0963-9.
[PMID] 32514157.
2021
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum.
Transplantation and cellular therapy.
27(7):533-539
[DOI] 10.1016/j.jtct.2021.04.008.
[PMID] 33895401.
2021
Gut Microbiota Dysbiosis Associated with Persistent Fatigue in Hematopoietic Cell Transplantation Survivors.
Transplantation and cellular therapy.
27(6):498.e1-498.e8
[DOI] 10.1016/j.jtct.2021.02.017.
[PMID] 33775619.
2021
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023.
Transplantation and cellular therapy.
27(2):183.e1-183.e7
[DOI] 10.1016/j.bbmt.2020.10.006.
[PMID] 33045387.
2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
Open Forum Infectious Diseases.
8(10)
[DOI] 10.1093/ofid/ofab441.
[PMID] 34631917.
2021
Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.
Transplantation and cellular therapy.
27(5):410-422
[DOI] 10.1016/j.jtct.2021.02.030.
[PMID] 33775617.
2021
Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease.
Hematology/oncology and stem cell therapy.
14(3):263-265
[DOI] 10.1016/j.hemonc.2021.03.004.
[PMID] 33785388.
2021
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
Journal of the Pediatric Infectious Diseases Society.
10(8):864-871
[DOI] 10.1093/jpids/piab036.
[PMID] 34173659.
2021
Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.
Cancer medicine.
10(1):70-78
[DOI] 10.1002/cam4.3568.
[PMID] 33169938.
2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
Transplantation and cellular therapy.
27(12):1007.e1-1007.e8
[DOI] 10.1016/j.jtct.2021.09.004.
[PMID] 34537422.
2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
Transplantation and cellular therapy.
27(6):507-516
[DOI] 10.1016/j.jtct.2021.03.015.
[PMID] 33865804.
2020
Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
26(11):2001-2010
[DOI] 10.1016/j.bbmt.2020.07.023.
[PMID] 32717434.
2020
Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients.
Hematology/oncology and stem cell therapy.
13(1):23-31
[DOI] 10.1016/j.hemonc.2019.08.003.
[PMID] 31629722.
2020
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
26(6):1210-1217
[DOI] 10.1016/j.bbmt.2020.02.011.
[PMID] 32088366.
2020
Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation Survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
26(6):1154-1159
[DOI] 10.1016/j.bbmt.2020.02.017.
[PMID] 32105830.
2020
Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection
PLOS Pathogens.
16(8)
[DOI] 10.1371/journal.ppat.1008741.
[PMID] 32750085.
2020
Global Metabolomics in Allogeneic Hematopoietic Cell Transplantation Recipients Discordant for Chronic Graft-versus-Host Disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
26(10):1803-1810
[DOI] 10.1016/j.bbmt.2020.06.014.
[PMID] 32592859.
2020
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis.
Bone marrow transplantation.
55(11):2121-2131
[DOI] 10.1038/s41409-020-0911-8.
[PMID] 32355289.
2020
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
26(12):2181-2189
[DOI] 10.1016/j.bbmt.2020.07.021.
[PMID] 32717432.
2020
Reply to Luppi et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
71(12)
[DOI] 10.1093/cid/ciaa324.
[PMID] 32412052.
2020
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
71(6):1367-1376
[DOI] 10.1093/cid/ciz1008.
[PMID] 31802125.
2020
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
British journal of haematology.
189(5):e211-e213
[DOI] 10.1111/bjh.16629.
[PMID] 32236943.
2020
Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.
Blood advances.
4(4):706-716
[DOI] 10.1182/bloodadvances.2019000923.
[PMID] 32092138.
2019
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.
Blood advances.
3(12):1837-1847
[DOI] 10.1182/bloodadvances.2018028316.
[PMID] 31208955.
2019
Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients.
Medical mycology.
57(1):38-44
[DOI] 10.1093/mmy/myx164.
[PMID] 29370415.
2019
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
25(2):362-368
[DOI] 10.1016/j.bbmt.2018.09.031.
[PMID] 30287390.
2019
Corrigendum to “Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features”.
Case reports in hematology.
2019
[DOI] 10.1155/2019/1548610.
[PMID] 31467738.
2019
Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.
JAMA.
322(17):1673-1681
[DOI] 10.1001/jama.2019.15702.
[PMID] 31688884.
2019
How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
68(5):850-853
[DOI] 10.1093/cid/ciy669.
[PMID] 30299481.
2019
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.
Blood advances.
3(17):2525-2536
[DOI] 10.1182/bloodadvances.2019000226.
[PMID] 31471322.
2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Blood advances.
3(19):2836-2844
[DOI] 10.1182/bloodadvances.2019000627.
[PMID] 31582392.
2019
Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
Haematologica.
104(5):1084-1092
[DOI] 10.3324/haematol.2018.203919.
[PMID] 30514795.
2019
Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
25(3):562-569
[DOI] 10.1016/j.bbmt.2018.10.005.
[PMID] 30315940.
2019
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.
Bone marrow transplantation.
54(8):1354-1360
[DOI] 10.1038/s41409-019-0457-9.
[PMID] 30696997.
2018
Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features.
Case reports in hematology.
2018
[DOI] 10.1155/2018/9052314.
[PMID] 29785311.
2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors
Biology of Blood and Marrow Transplantation.
24(6):1119-1124
[DOI] 10.1016/j.bbmt.2018.03.023.
2018
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.
The Lancet. Haematology.
5(11):e563-e598
[DOI] 10.1016/S2352-3026(18)30051-6.
[PMID] 29907552.
2018
CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation.
Leukemia research.
74:110-112
[DOI] 10.1016/j.leukres.2018.10.007.
[PMID] 30401521.
2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
Clinical Cancer Research.
24(17):4098-4109
[DOI] 10.1158/1078-0432.ccr-18-0449.
2018
Lifestyle Behaviors, Perceived Stress, and Inflammation of Individuals With Chronic Graft-Versus-Host Disease.
Cancer nursing.
41(1):11-22
[DOI] 10.1097/NCC.0000000000000453.
[PMID] 27922915.
2018
PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.
Journal of clinical microbiology.
56(10)
[DOI] 10.1128/JCM.00746-18.
[PMID] 30068535.
2018
Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
Journal of clinical apheresis.
33(1):29-37
[DOI] 10.1002/jca.21556.
[PMID] 28556233.
2018
Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.
Bone marrow transplantation.
53(8):1038-1043
[DOI] 10.1038/s41409-018-0138-0.
[PMID] 29515249.
2018
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
24(7):1322-1340
[DOI] 10.1016/j.bbmt.2018.02.009.
[PMID] 29471034.
2018
The microbiome: more than a gut reaction
Blood.
131(26):2874-2875
[DOI] 10.1182/blood-2018-05-847509.
2018
Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.
Vaccine.
36(41):6043-6052
[DOI] 10.1016/j.vaccine.2018.08.044.
[PMID] 30195488.
2017
A Prospective Biopsychosocial Investigation Into Head and Neck Cancer Caregiving.
Biological research for nursing.
19(1):87-96
[DOI] 10.1177/1099800416660760.
[PMID] 27465999.
2017
Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity.
Respiratory medicine case reports.
21:154-157
[DOI] 10.1016/j.rmcr.2017.05.003.
[PMID] 28560147.
2017
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
Clinical pharmacology and therapeutics.
102(1):45-51
[DOI] 10.1002/cpt.583.
[PMID] 27981572.
2017
Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide.
Bone marrow transplantation.
52(8):1204-1205
[DOI] 10.1038/bmt.2017.94.
[PMID] 28581471.
2017
Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.
Molecular therapy. Methods & clinical development.
4:178-191
[DOI] 10.1016/j.omtm.2016.12.003.
[PMID] 28345003.
2017
Guarded promise for adenovirus therapy
Blood.
129(14):1899-1900
[DOI] 10.1182/blood-2017-02-767582.
2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia.
Blood cancer journal.
7(12)
[DOI] 10.1038/s41408-017-0007-x.
[PMID] 29176662.
2017
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
23(6):870-881
[DOI] 10.1016/j.bbmt.2016.10.001.
[PMID] 27751936.
2017
Paroxysmal Nocturnal Hemoglobinuria in Pregnancy: A Dilemma in Treatment and Thromboprophylaxis.
Case reports in hematology.
2017
[DOI] 10.1155/2017/7289126.
[PMID] 29147590.
2017
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.
Bone marrow transplantation.
52(2):270-278
[DOI] 10.1038/bmt.2016.259.
[PMID] 27991895.
2017
Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
23(1):161-164
[DOI] 10.1016/j.bbmt.2016.10.007.
[PMID] 27742574.
2017
Recent advances in hematopoietic stem cell transplantation
F1000Research.
6
[DOI] 10.12688/f1000research.11233.1.
[PMID] 28663793.
2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.
Leukemia research.
46:69-73
[DOI] 10.1016/j.leukres.2016.04.013.
[PMID] 27132034.
2016
A sniff to chase ill humors away
Blood.
128(7):889-890
[DOI] 10.1182/blood-2016-06-723932.
2016
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation.
51(9):1228-32
[DOI] 10.1038/bmt.2016.92.
[PMID] 27088382.
2016
Burden, quality of life, and social support in caregivers of patients undergoing radiotherapy for head and neck cancer: A pilot study.
Chronic illness.
12(3):236-45
[DOI] 10.1177/1742395316644305.
[PMID] 27068111.
2016
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.
Blood.
127(20):2427-38
[DOI] 10.1182/blood-2015-11-679639.
[PMID] 26884374.
2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.
Clinical transplantation.
30(8):894-900
[DOI] 10.1111/ctr.12762.
[PMID] 27219740.
2016
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
Cytotherapy.
18(3):465-80
[DOI] 10.1016/j.jcyt.2015.12.007.
[PMID] 26857235.
2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
63(4):433-42
[DOI] 10.1093/cid/ciw444.
[PMID] 27481947.
2016
Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
Bone marrow transplantation.
51(8):1113-20
[DOI] 10.1038/bmt.2016.89.
[PMID] 27042847.
2016
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
22(9):1636-1645
[DOI] 10.1016/j.bbmt.2016.06.012.
[PMID] 27343716.
2016
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
22(2):359-370
[DOI] 10.1016/j.bbmt.2015.09.013.
[PMID] 26409243.
2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial
Biology of Blood and Marrow Transplantation.
22(12):2256-2263
[DOI] 10.1016/j.bbmt.2016.08.016.
[PMID] 27565521.
2016
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Cancer.
122(1):91-8
[DOI] 10.1002/cncr.29717.
[PMID] 26439325.
2016
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
22(11):1915-1925
[DOI] 10.1016/j.bbmt.2016.07.013.
[PMID] 27481448.
2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
63(4):e1-e60
[DOI] 10.1093/cid/ciw326.
[PMID] 27365388.
2016
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
22(6):1108-1116
[DOI] 10.1016/j.bbmt.2016.02.018.
[PMID] 27013014.
2016
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
Bone marrow transplantation.
51(2)
[DOI] 10.1038/bmt.2015.318.
[PMID] 26838373.
2016
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
Bone marrow transplantation.
51(2):277-82
[DOI] 10.1038/bmt.2015.263.
[PMID] 26524262.
2016
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.
Bone marrow transplantation.
51(4):573-80
[DOI] 10.1038/bmt.2015.316.
[PMID] 26726945.
2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.
The Journal of antimicrobial chemotherapy.
71(8):2234-40
[DOI] 10.1093/jac/dkw127.
[PMID] 27121401.
2015
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
Bone marrow transplantation.
50(2):197-203
[DOI] 10.1038/bmt.2014.259.
[PMID] 25402415.
2015
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(10):1830-8
[DOI] 10.1016/j.bbmt.2015.06.013.
[PMID] 26116089.
2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
61(8):1293-303
[DOI] 10.1093/cid/civ507.
[PMID] 26113653.
2015
Blood and marrow transplant clinical trials network state of the Science Symposium 2014.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(2):202-24
[DOI] 10.1016/j.bbmt.2014.10.003.
[PMID] 25445636.
2015
Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(4):640-5
[DOI] 10.1016/j.bbmt.2014.10.022.
[PMID] 25528390.
2015
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Annals of internal medicine.
162(2):81-9
[DOI] 10.7326/M13-2508.
[PMID] 25599346.
2015
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(10):1815-22
[DOI] 10.1016/j.bbmt.2015.06.004.
[PMID] 26071866.
2015
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(4):688-95
[DOI] 10.1016/j.bbmt.2014.12.017.
[PMID] 25543094.
2015
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(7):1155-66
[DOI] 10.1016/j.bbmt.2015.03.002.
[PMID] 25769794.
2015
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(11):1870-82
[DOI] 10.1016/j.bbmt.2015.07.033.
[PMID] 26256943.
2015
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research.
21(9):2020-8
[DOI] 10.1158/1078-0432.CCR-14-0586.
[PMID] 25348512.
2015
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
PloS one.
10(11)
[DOI] 10.1371/journal.pone.0143165.
[PMID] 26581097.
2015
Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.
Blood.
125(24):3778-88
[DOI] 10.1182/blood-2014-07-587329.
[PMID] 25904246.
2015
Patient and Provider Preferences for Survivorship Care Plans for Allogeneic Hematopoietic Cell Transplantation (Hct) Survivors: a Qualitative Study
Biology of Blood and Marrow Transplantation.
21(2, 1):S174-S175
[DOI] 10.1016/j.bbmt.2014.11.256.
2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).
Medical mycology.
53(5):440-6
[DOI] 10.1093/mmy/myv018.
[PMID] 25908651.
2015
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
21(1):165-71
[DOI] 10.1016/j.bbmt.2014.10.007.
[PMID] 25316111.
2015
Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
23(3):797-807
[DOI] 10.1007/s00520-014-2420-z.
[PMID] 25193598.
2015
Secondary solid cancer screening following hematopoietic cell transplantation.
Bone marrow transplantation.
50(8):1013-23
[DOI] 10.1038/bmt.2015.63.
[PMID] 25822223.
2015
Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome.
Leukemia research reports.
4(1):24-7
[DOI] 10.1016/j.lrr.2015.03.002.
[PMID] 25893166.
2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.
Annals of internal medicine.
162(1):1-10
[DOI] 10.7326/M13-2729.
[PMID] 25560711.
2015
Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and Caucasians.
Transfusion.
55(7):1766-71
[DOI] 10.1111/trf.13124.
[PMID] 25903156.
2014
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
[Rinsho ketsueki] The Japanese journal of clinical hematology.
55(6):607-32
[PMID] 24975331.
2014
Advances in the management of viral infections.
Cancer treatment and research.
161:157-80
[DOI] 10.1007/978-3-319-04220-6_5.
[PMID] 24706224.
2014
Aztreonam for febrile neutropenia in patients with beta-lactam allergy.
Transplant infectious disease : an official journal of the Transplantation Society.
16(1):145-52
[DOI] 10.1111/tid.12148.
[PMID] 24119095.
2014
Clinical guide to fertility preservation in hematopoietic cell transplant recipients.
Bone marrow transplantation.
49(4):477-84
[DOI] 10.1038/bmt.2013.211.
[PMID] 24419521.
2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(5):600-16
[DOI] 10.1016/j.bbmt.2014.01.019.
[PMID] 24462742.
2014
Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.
British journal of haematology.
166(4):619-21
[DOI] 10.1111/bjh.12885.
[PMID] 24697357.
2014
Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(10):1530-6
[DOI] 10.1016/j.bbmt.2014.05.027.
[PMID] 24910380.
2014
Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(1):118-27
[DOI] 10.1016/j.bbmt.2013.10.024.
[PMID] 24184336.
2014
Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.
Journal of clinical microbiology.
52(6):2108-11
[DOI] 10.1128/JCM.03500-13.
[PMID] 24719449.
2014
Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(9):1262-73
[DOI] 10.1016/j.bbmt.2014.05.003.
[PMID] 24816581.
2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(6):858-64
[DOI] 10.1016/j.bbmt.2014.02.026.
[PMID] 24607553.
2014
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
Journal of clinical microbiology.
52(6):2199-201
[DOI] 10.1128/JCM.00285-14.
[PMID] 24719434.
2014
Reply to “Insufficient demonstration of long-term stability of Aspergillus galactomannan”.
Journal of clinical microbiology.
52(11)
[DOI] 10.1128/JCM.02433-14.
[PMID] 25324241.
2014
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
20(11):1777-84
[DOI] 10.1016/j.bbmt.2014.07.009.
[PMID] 25042734.
2014
Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study.
Clinical Medicine Insights. Oncology.
8:101-5
[DOI] 10.4137/CMO.S16835.
[PMID] 25232286.
2014
Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
59 Suppl 5:S352-5
[DOI] 10.1093/cid/ciu639.
[PMID] 25352630.
2013
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Blood.
121(1):197-206
[DOI] 10.1182/blood-2012-03-417667.
[PMID] 23109243.
2013
Association of Mannose Binding Lectin (Mbl) Levels and Invasive Fungal Disease (Ifd) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (Hsct) Or Receiving Chemotherapy
Biology of Blood and Marrow Transplantation.
19(2):S226-S227
[DOI] 10.1016/j.bbmt.2012.11.274.
2013
Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
19(7):1126-9
[DOI] 10.1016/j.bbmt.2013.04.011.
[PMID] 23611977.
2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
70(17):1518-27
[DOI] 10.2146/ajhp120599.
[PMID] 23943184.
2013
Continuous Infusion Cyclophosphamide and Low Dose Total Body Irradiation (Cicy/Ldtbi) as a Conditioning Regimen for Tandem Autologous Transplant in Multiple Myeloma
Biology of Blood and Marrow Transplantation.
19(2)
[DOI] 10.1016/j.bbmt.2012.11.173.
2013
Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple myeloma.
Transplantation proceedings.
45(9):3361-5
[DOI] 10.1016/j.transproceed.2013.03.054.
[PMID] 24182816.
2013
Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis.
Journal of clinical microbiology.
51(7):2403-5
[DOI] 10.1128/JCM.00744-13.
[PMID] 23616459.
2013
Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.
Journal of the National Comprehensive Cancer Network : JNCCN.
11(8):941-9
[PMID] 23946173.
2013
Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.
Bone marrow transplantation.
48(1):10-8
[DOI] 10.1038/bmt.2012.26.
[PMID] 22410751.
2013
Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients.
Bone marrow transplantation.
48(8):1091-7
[DOI] 10.1038/bmt.2013.13.
[PMID] 23419436.
2013
Randomized, Double Blind, Placebo-Controlled Trial of a Tnf Inhibitor (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (Ips) After Allogeneic Stem Cell Transplant (Sct). a Blood and Marrow Transplant Clinical Trials Network (Bmt Ctn) Study
Biology of Blood and Marrow Transplantation.
19(2)
[DOI] 10.1016/j.bbmt.2012.11.141.
2013
Second malignancies after autologous hematopoietic cell transplantation in children.
Bone marrow transplantation.
48(3):363-8
[DOI] 10.1038/bmt.2012.166.
[PMID] 22964594.
2013
Social Support as a Facilitator To the Blood and Marrow Transplantation Treatment Experience Among Cancer Survivors and Their Spouse Caregivers
Psycho-Oncology.
22
2013
Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?
Bone marrow transplantation.
48(7):884-9
[DOI] 10.1038/bmt.2012.163.
[PMID] 22941377.
2012
A Phase I Study of the Vascular Disrupting Combretastatin, Oxi4503, in Patients With Relapsed and Refractory Acute Myeloid Leukemia (Aml) and Myelodysplastic Syndromes (Mds)
Blood.
120
2012
African American adult apheresis donors respond to granulocyte-colony-stimulating factor with neutrophil and progenitor cell yields comparable to those of Caucasian and Hispanic donors.
Transfusion.
52(1):166-72
[DOI] 10.1111/j.1537-2995.2011.03253.x.
[PMID] 21790625.
2012
Armed killers face off against cytomegalovirus.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(7):977-8
[DOI] 10.1016/j.bbmt.2012.05.001.
[PMID] 22575815.
2012
Characteristics of thawed autologous umbilical cord blood.
Transfusion.
52(10):2234-42
[DOI] 10.1111/j.1537-2995.2011.03556.x.
[PMID] 22321210.
2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
30(26):3194-201
[DOI] 10.1200/JCO.2012.41.7071.
[PMID] 22869882.
2012
Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.
Expert review of hematology.
5(6):661-9
[DOI] 10.1586/ehm.12.53.
[PMID] 23216596.
2012
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(8):1150-63
[DOI] 10.1016/j.bbmt.2012.04.005.
[PMID] 22510384.
2012
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
Best practice & research. Clinical haematology.
25(4):487-91
[DOI] 10.1016/j.beha.2012.10.013.
[PMID] 23200547.
2012
Higher Than Expected Incidence of Chronic Myeloid Leukemia in Solid Organ Transplant Recipients.
Blood.
120
2012
How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation.
Blood.
120(9):1791-800
[DOI] 10.1182/blood-2012-02-378976.
[PMID] 22692506.
2012
Impact of Chronic Gvhd On Late Relapse, Treatment Related Mortality and Survival After Allogeneic Hematopoietic Cell Transplantation for Hematological Malignancies
Biology of Blood and Marrow Transplantation.
18(2):S209-S210
[DOI] 10.1016/j.bbmt.2011.12.021.
2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society.
14(5):468-78
[DOI] 10.1111/j.1399-3062.2012.00732.x.
[PMID] 22548788.
2012
Peripheral Blood Cd34(+) Specific Donor Chimerism Analysis as An Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients With Myelodysplastic Syndromes and Acute Myelogenous Leukemia.
Blood.
120
2012
Peripheral-blood stem cells versus bone marrow from unrelated donors.
The New England journal of medicine.
367(16):1487-96
[DOI] 10.1056/NEJMoa1203517.
[PMID] 23075175.
2012
Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(12):1851-8
[DOI] 10.1016/j.bbmt.2012.06.016.
[PMID] 22766223.
2012
Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.
Seminars in hematology.
49(1):104-9
[DOI] 10.1053/j.seminhematol.2011.10.004.
[PMID] 22221790.
2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(3):348-71
[DOI] 10.1016/j.bbmt.2011.12.519.
[PMID] 22178693.
2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Revista brasileira de hematologia e hemoterapia.
34(2):109-33
[DOI] 10.5581/1516-8484.20120032.
[PMID] 23049402.
2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Hematology/oncology and stem cell therapy.
5(1):1-30
[DOI] 10.5144/1658-3876.2012.1.
[PMID] 22446607.
2012
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Bone marrow transplantation.
47(3):337-41
[DOI] 10.1038/bmt.2012.5.
[PMID] 22395764.
2012
Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(6):903-12
[DOI] 10.1016/j.bbmt.2011.10.040.
[PMID] 22062801.
2012
Response Post-First Autologous Stem Cell Transplantation for Multiple Myeloma May Identify Patients Who Will Benefit From Tandem Transplants: a Single Center Prospective Phase II Study- An Update
Blood.
120
2012
Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
18(12):1927-34
[DOI] 10.1016/j.bbmt.2012.07.013.
[PMID] 22824184.
2012
Single Versus Tandem Autologous Stem Cell Transplantation (Asct) for Multiple Myeloma Patients and Role of Second Salvage Transplant: a Single Center Prospective Phase Ii Study
Biology of Blood and Marrow Transplantation.
18(2)
[DOI] 10.1016/j.bbmt.2011.12.244.
2012
Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After Hla-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402
Blood.
120
2012
Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
Current opinion in hematology.
19(1):21-6
[DOI] 10.1097/MOH.0b013e32834da9bf.
[PMID] 22080847.
2011
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.
Blood.
118(2):282-8
[DOI] 10.1182/blood-2011-03-344853.
[PMID] 21527516.
2011
Assessing responses to treatment of opportunistic mycoses and salvage strategies.
Current infectious disease reports.
13(6):492-503
[DOI] 10.1007/s11908-011-0217-5.
[PMID] 21948189.
2011
Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide.
Diabetes care.
34(12):2567-9
[DOI] 10.2337/dc11-1406.
[PMID] 22011412.
2011
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
Blood.
117(24):6714-20
[DOI] 10.1182/blood-2010-12-323824.
[PMID] 21493797.
2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
52(4):e56-93
[DOI] 10.1093/cid/cir073.
[PMID] 21258094.
2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
52(4):427-31
[DOI] 10.1093/cid/ciq147.
[PMID] 21205990.
2011
Comparison of lasting life changes after cancer and BMT: perspectives of long-term survivors and spouses.
Psycho-oncology.
20(9):926-34
[DOI] 10.1002/pon.1812.
[PMID] 20690114.
2011
Early Post-Donation Health-Related Quality-Of-Life and Recovery Among Adult Unrelated Stem Cell Donors: a Planned Subgroup Analysis of a Randomized Trial of Marrow Versus Pbsc Donation
.
46:S72-S73
2011
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
17(7):1043-50
[DOI] 10.1016/j.bbmt.2010.11.013.
[PMID] 21087680.
2011
Generic immunosuppressants in hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
17(3):285-90
[DOI] 10.1016/j.bbmt.2010.11.006.
[PMID] 21087678.
2011
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Hematology/oncology clinics of North America.
25(1):101-16
[DOI] 10.1016/j.hoc.2010.11.008.
[PMID] 21236393.
2011
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Emerging infectious diseases.
17(10):1855-64
[DOI] 10.3201/eid1710.110087.
[PMID] 22000355.
2011
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
29(16):2230-9
[DOI] 10.1200/JCO.2010.33.7212.
[PMID] 21464398.
2011
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
17(12):1783-9
[DOI] 10.1016/j.bbmt.2011.05.008.
[PMID] 21658461.
2011
Pandemic influenza: was the concern warranted?
Blood.
117(19):5012-3
[DOI] 10.1182/blood-2011-03-341511.
[PMID] 21566098.
2011
Phase II Trial of Non-Myeloablative Conditioning and Partially Hla-Mismatched (Hla-Haploidentical) Bone Marrow Transplantation (Bmt) for Patients With Hematologic Malignancies: Results of Blood and Marrow Transplant Clinical Trials Network (Bmt Ctn) Protocol 0603
Biology of Blood and Marrow Transplantation.
17(2)
[DOI] 10.1016/j.bbmt.2010.12.007.
2011
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
17(2):157-66
[DOI] 10.1016/j.bbmt.2010.07.009.
[PMID] 20659574.
2011
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.
Blood.
118(16):4472-9
[DOI] 10.1182/blood-2011-04-349068.
[PMID] 21878671.
2011
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
Blood.
117(1):316-22
[DOI] 10.1182/blood-2010-07-294629.
[PMID] 20926773.
2011
The Impact of Increasing the Pre-Processing Total Nucleated Cell Count Banking Threshold On Racial and Ethnic Diversity in Cord Blood Banking
Transfusion.
51:279A-280A
2011
Transplant Physician Perceptions and Practice Patterns Regarding Fertility Preservation in Hematopoietic-Cell Transplant (Hct) Recipients
Biology of Blood and Marrow Transplantation.
17(2)
[DOI] 10.1016/j.bbmt.2010.12.263.
2011
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
17(9):1375-82
[DOI] 10.1016/j.bbmt.2011.01.012.
[PMID] 21277376.
2010
Antifungal management.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
16(3):441-2
[DOI] 10.1016/j.bbmt.2008.05.011.
[PMID] 20152732.
2010
Aspergillus DNA contamination in blood collection tubes.
Diagnostic microbiology and infectious disease.
67(4):392-4
[DOI] 10.1016/j.diagmicrobio.2010.02.028.
[PMID] 20638611.
2010
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study.
Clinical Medicine Insights. Oncology.
4:117-25
[DOI] 10.4137/CMO.S6161.
[PMID] 21151584.
2010
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
Medicine.
89(4):236-244
[DOI] 10.1097/MD.0b013e3181e9441b.
[PMID] 20616663.
2010
Factors associated with mortality in transplant patients with invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
50(12):1559-67
[DOI] 10.1086/652768.
[PMID] 20450350.
2010
Factors associated with self-reported physical and mental health after hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
16(12):1682-92
[DOI] 10.1016/j.bbmt.2010.05.017.
[PMID] 20685400.
2010
Health-Related Quality-Of-Life Among Adult Matched Unrelated Stem Cell Donors: a Blood and Marrow Transplant Clinical Trials Network (Bmt Ctn) Randomized Trial of Marrow Versus Pbsc Donation
Blood.
116:165-166
2010
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Infectious disease clinics of North America.
24(2):257-72
[DOI] 10.1016/j.idc.2010.01.010.
[PMID] 20466269.
2010
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Clinical advances in hematology & oncology : H&O.
8(1):40-6
[PMID] 20351682.
2010
Multi-Site Study of Caregiver Outcomes During Hematopoietic Cell Transplantation (Hct)
Annals of Behavioral Medicine.
39
2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
50(8):1091-100
[DOI] 10.1086/651263.
[PMID] 20218877.
2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
Blood.
116(24):5111-8
[DOI] 10.1182/blood-2010-02-268151.
[PMID] 20826719.
2010
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
Bone marrow transplantation.
45(1):31-7
[DOI] 10.1038/bmt.2009.126.
[PMID] 19543325.
2010
Risk Factors for Major Transplant Related Outcomes in Pediatric Patients With Chronic Graft-Versus-Host Disease
Blood.
116:97-98
2010
Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia.
PLoS pathogens.
6(3)
[DOI] 10.1371/journal.ppat.1000827.
[PMID] 20361054.
2010
Spiritual absence and 1-year mortality after hematopoietic stem cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
16(8):1171-9
[DOI] 10.1016/j.bbmt.2010.03.003.
[PMID] 20227510.
2010
The National Marrow Donor Program’s symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
16(2):147-56
[DOI] 10.1016/j.bbmt.2009.08.004.
[PMID] 20142045.
2010
The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
16(2):207-14
[DOI] 10.1016/j.bbmt.2009.09.015.
[PMID] 19781657.
2009
Autologous umbilical cord blood transfusion in very young children with type 1 diabetes.
Diabetes care.
32(11):2041-6
[DOI] 10.2337/dc09-0967.
[PMID] 19875605.
2009
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Mycopathologia.
168(6):299-311
[DOI] 10.1007/s11046-009-9188-6.
[PMID] 19247798.
2009
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.
Blood.
114(3):511-7
[DOI] 10.1182/blood-2009-03-212290.
[PMID] 19443659.
2009
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood.
113(21):5074-82
[DOI] 10.1182/blood-2009-02-202937.
[PMID] 19270260.
2009
Fungal infection prevention after hematopoietic cell transplantation.
Bone marrow transplantation.
44(8):483-7
[DOI] 10.1038/bmt.2009.259.
[PMID] 19861982.
2009
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.
Bone marrow transplantation.
44(8):453-5
[DOI] 10.1038/bmt.2009.254.
[PMID] 19861977.
2009
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
15(10):1143-238
[DOI] 10.1016/j.bbmt.2009.06.019.
[PMID] 19747629.
2009
Impact of Azacytidine Induction Chemotherapies On Post-Transplant Outcomes in Patients With Myelodysplastic Syndromes
Journal of Clinical Oncology.
27
2009
Long-Term Survival and Late Deaths in 2-Year Survivors of Myeloablative Allogeneic Hematopoietic-Cell Transplantation for Hematologic Disorders
Blood.
114:215-216
2009
Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
15(6):761-2
[DOI] 10.1016/j.bbmt.2009.02.008.
[PMID] 19450763.
2009
Solid cancers after allogeneic hematopoietic cell transplantation.
Blood.
113(5):1175-83
[DOI] 10.1182/blood-2008-05-158782.
[PMID] 18971419.
2009
Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics.
Critical reviews in oncology/hematology.
72(2):144-54
[DOI] 10.1016/j.critrevonc.2009.01.003.
[PMID] 19237297.
2009
Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society.
11(2):143-8
[DOI] 10.1111/j.1399-3062.2008.00360.x.
[PMID] 19144095.
2009
Tacrolimus and “Mini” Methotrexate Is An Effective Regimen for Prevention of Graft-Versus-Host-Disease in Children Undergoing Umbilical Cord Blood Transplant
Biology of Blood and Marrow Transplantation.
15(2)
[DOI] 10.1016/j.bbmt.2008.12.249.
2009
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
Blood.
113(13):3110-8
[DOI] 10.1182/blood-2008-07-163212.
[PMID] 19059878.
2008
Bmt Ctn 0302: a Phase Ii Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (Mmf), Denileukin Diftitox, and Pentostatin in Combination With Corticosteroids in 180 Patients (Pts) With Newly Diagnosed Acute Graft Vs. Host Disease (Agvhd)
Blood.
112:27-28
2008
Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following lethal irradiation.
Experimental hematology.
36(9):1143-1156
[DOI] 10.1016/j.exphem.2008.06.009.
[PMID] 18718416.
2008
Changes in causes of death over time after treatment for invasive aspergillosis.
Cancer.
112(10):2309-12
[DOI] 10.1002/cncr.23441.
[PMID] 18338758.
2008
Combination antifungal therapy: from bench to bedside.
Current infectious disease reports.
10(6):466-72
[PMID] 18945387.
2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
47(5):674-83
[DOI] 10.1086/590566.
[PMID] 18637757.
2008
Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.
Leukemia & lymphoma.
49(2):306-14
[DOI] 10.1080/10428190701813018.
[PMID] 18231918.
2008
Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis.
Journal of clinical microbiology.
46(5):1647-54
[DOI] 10.1128/JCM.02018-07.
[PMID] 18322056.
2008
Influenza: preparedness for an inevitable “Emergency” for oncology and BMT units.
Journal of the National Comprehensive Cancer Network : JNCCN.
6(2):215-22
[PMID] 18319053.
2008
Learning from our failures: the antifungal treatment conundrum.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
46(9):1434-5
[DOI] 10.1086/587102.
[PMID] 18419448.
2008
Non-Myeloablative Allogeneic Stem Cell Transplantation To Treat High Risk Heavily Pretreated Multiple
Biology of Blood and Marrow Transplantation.
14(2):69-70
[DOI] 10.1016/j.bbmt.2007.12.198.
2008
Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.
Clinical and vaccine immunology : CVI.
15(12):1760-3
[DOI] 10.1128/CVI.00226-08.
[PMID] 18845830.
2008
Prevention of Late Cmv Disease After Hct: a Randomized Double-Blind Multicenter Trial of Valganciclovir (Vgcv) Prophylaxis Versus Pcr-Guided Gcv/Vgcv Preemptive Therapy
Biology of Blood and Marrow Transplantation.
14(2)
[DOI] 10.1016/j.bbmt.2007.12.083.
2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
46(12):1813-21
[DOI] 10.1086/588660.
[PMID] 18462102.
2008
Similar Graft-Versus-Leukemia Effect Using Matched Unrelated Donors, Compared To Hla-Identical Siblings for Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation.
14(2):14-15
[DOI] 10.1016/j.bbmt.2007.12.041.
2008
Transplanted human cord blood cells generate amylase-producing pancreatic acinar cells in engrafted mice.
Pancreas.
36(2):e30-5
[DOI] 10.1097/MPA.0b013e3181584656.
[PMID] 18376297.
2008
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
46(3):327-60
[DOI] 10.1086/525258.
[PMID] 18177225.
2007
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
13(11):1268-85
[PMID] 17950914.
2007
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
Journal of clinical microbiology.
45(6):1759-65
[PMID] 17428933.
2007
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
44(3):373-9
[PMID] 17205443.
2007
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
25(11):1403-11
[PMID] 17416860.
2007
New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients.
Best practice & research. Clinical haematology.
20(1):99-107
[PMID] 17336260.
2007
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
The Journal of infectious diseases.
195(3):455-66
[PMID] 17205486.
2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
13(12):1461-8
[PMID] 18022576.
2007
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
64(6):637-43
[PMID] 17353573.
2007
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
44(3):402-9
[PMID] 17205448.
2007
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
Transplant infectious disease : an official journal of the Transplantation Society.
9(3):182-8
[PMID] 17605747.
2007
Sites and kinetics of donor thrombopoiesis following transplantation of whole bone marrow and progenitor subsets.
Experimental hematology.
35(10):1567-79
[PMID] 17697746.
2007
Spatial distribution of blood vessels and CD34+ hematopoietic stem and progenitor cells within the marrow cavities of human cancellous bone.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
48(4):645-54
[PMID] 17401104.
2007
The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant.
Stem cells (Dayton, Ohio).
25(11):2945-55
[PMID] 17656638.
2007
Umbilical cord blood produces small megakaryocytes after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
13(2):145-50
[PMID] 17241920.
2007
Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience.
Pediatric transplantation.
11(6):641-4
[PMID] 17663687.
2007
Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
Journal of clinical microbiology.
45(9):2787-92
[PMID] 17596367.
2006
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
43(8):1031-9
[PMID] 16983616.
2006
Factors associated with parameters of engraftment potential of umbilical cord blood.
Transfusion.
46(10):1803-12
[PMID] 17002638.
2006
Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?
Current opinion in infectious diseases.
19(4):371-9
[PMID] 16804386.
2006
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Blood reviews.
20(5):267-87
[PMID] 16781028.
2006
Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
12(3):325-34
[PMID] 16503502.
2006
Posaconazole as salvage therapy for zygomycosis.
Antimicrobial agents and chemotherapy.
50(1):126-33
[PMID] 16377677.
2006
Preparing for the unthinkable: emergency preparedness for the hematopoietic cell transplant program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
12(11):1229-38
[PMID] 17085317.
2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Bone marrow transplantation.
37(3):249-61
[PMID] 16435004.
2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
12(2):138-51
[PMID] 16443512.
2005
An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
11(7):487-94
[PMID] 15983548.
2005
Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis.
Clinical therapeutics.
27(6):960-9
[PMID] 16117996.
2005
Developmental differences in megakaryocyte maturation are determined by the microenvironment.
Stem cells (Dayton, Ohio).
23(9):1400-8
[PMID] 16210411.
2005
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
41(3):308-10
[PMID] 16007525.
2005
Highlights from the 46 th annual meeting of the American Society of Hematology.
Clinical advances in hematology & oncology : H&O.
3(2):111-6
[PMID] 16166978.
2005
Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
11(9):698-705
[PMID] 16125640.
2005
Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
11(12):1014-21
[PMID] 16338624.
2005
Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
23(3):599-608
[PMID] 15659507.
2005
Multicenter clinical evaluation of the (1–>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
41(5):654-9
[PMID] 16080087.
2005
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
11(12):945-56
[PMID] 16338616.
2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
41(10):1448-52
[PMID] 16231256.
2005
Study of renal safety in amphotericin B lipid complex-treated patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
40 Suppl 6:S414-21
[PMID] 15809928.
2005
The changing face of invasive fungal infections in hematopoietic cell transplant recipients.
Current opinion in oncology.
17(2):89-92
[PMID] 15725910.
2005
The evolution of the evidence-based review: evaluating the science enhances the art of medicine–statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
11(11):819-22
[PMID] 16275587.
2005
Treatment of zygomycosis with posaconazole in a patient with acute myeloid leukemia.
Clinical advances in hematology & oncology : H&O.
3(10):773-7
[PMID] 16258487.
2004
A new era of antifungal therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
10(2):73-90
[PMID] 14750074.
2004
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Leukemia research.
28(6):559-65
[PMID] 15120931.
2004
Bone marrow transdifferentiation in brain after transplantation: a retrospective study.
Lancet (London, England).
363(9419):1432-7
[PMID] 15121406.
2004
Clinical consequences of oral mucositis.
Seminars in oncology nursing.
20(1):16-21
[PMID] 15038513.
2004
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
39 Suppl 4:S176-80
[PMID] 15546114.
2004
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
10(9):614-23
[PMID] 15319773.
2004
Empirical antifungal therapy in treating febrile neutropenic patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
39 Suppl 1:S38-43
[PMID] 15250019.
2004
Granulocytic sarcoma (chloroma) of the breast: a diagnostic dilemma and review of the literature.
The breast journal.
10(1):48-53
[PMID] 14717760.
2004
Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease.
Blood.
103(11):4330-5
[PMID] 14962904.
2004
Physicians’ attitudes about quality-of-life issues in hematopoietic stem cell transplantation.
Blood.
104(7):2194-200
[PMID] 15198954.
2004
Supportive care.
Hematology. American Society of Hematology. Education Program.
372-89
[PMID] 15561693.
2004
The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
39 Suppl 4:S165-9
[PMID] 15546112.
2004
Thriving after hematopoietic stem cell transplant: a focus on positive changes in quality of life.
Expert review of pharmacoeconomics & outcomes research.
4(1):111-23
[DOI] 10.1586/14737167.4.1.111.
[PMID] 19807341.
2004
Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
Bone marrow transplantation.
34(5):405-11
[PMID] 15247929.
2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Leukemia & lymphoma.
44(7):1165-72
[PMID] 12916869.
2003
Access to stem cell transplantation: do women fare as well as men?
American journal of hematology.
72(2):99-102
[PMID] 12555212.
2003
Autologous stem cell transplantation in multiple myeloma patients /=60 years of age.
Bone marrow transplantation.
32(12):1135-43
[PMID] 14647267.
2003
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
American journal of hematology.
73(3):169-75
[PMID] 12827653.
2003
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
9(9):543-58
[PMID] 14506657.
2003
Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
Cancer.
98(2):406-12
[PMID] 12872363.
2003
Human cord blood long-term engrafting cells are CD34+ CD38-.
Leukemia.
17(5):960-4
[PMID] 12750710.
2003
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
9(11):722-4
[PMID] 14682302.
2003
Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation.
Leukemia & lymphoma.
44(5):815-20
[PMID] 12802919.
2003
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
9(1):4-37
[PMID] 12533739.
2003
Transplanted human cord blood cells give rise to hepatocytes in engrafted mice.
Annals of the New York Academy of Sciences.
996:174-85
[PMID] 12799295.
2003
Typhlitis with concurrent appendicitis in a patient with chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O.
1(5):284-6; discussion 286
[PMID] 16224422.
2002
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
35(4):359-66
[PMID] 12145716.
2002
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
8(10):569-76
[PMID] 12434952.
2002
An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice.
Experimental hematology.
30(5):488-94
[PMID] 12031656.
2002
Antifungal chemoprophylaxis after blood and marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
34(10):1386-90
[PMID] 11981735.
2002
Clinical research: the best or worst of times?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
8(6):293-4
[PMID] 12108914.
2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
8(3):145-54
[PMID] 11939604.
2002
GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
Cytotherapy.
4(6):531-8
[PMID] 12568989.
2002
Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
Stem cells (Dayton, Ohio).
20(2):174-82
[PMID] 11897874.
2002
Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Experimental hematology.
30(7):816-23
[PMID] 12135681.
2002
Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Journal of hematotherapy & stem cell research.
11(2):277-92
[PMID] 11983099.
2002
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
8(9):493-500
[PMID] 12374454.
2002
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Bone marrow transplantation.
29(1):15-9
[PMID] 11840139.
2002
Lipid formulations of amphotericins: are you a lumper or a splitter?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
35(7):891-5
[PMID] 12228829.
2002
Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation.
Bone marrow transplantation.
29(11):875-80
[PMID] 12080350.
2002
Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?
Current opinion in infectious diseases.
15(4):369-75
[PMID] 12130932.
2002
Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors.
Transfusion.
42(10):1279-84
[PMID] 12423511.
2002
Stem cell transplantation: supportive care and long-term complications.
Hematology. American Society of Hematology. Education Program.
422-44
[PMID] 12446435.
2002
Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.
Leukemia & lymphoma.
43(5):989-99
[PMID] 12148910.
2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
The New England journal of medicine.
346(4):225-34
[PMID] 11807146.
2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine.
347(6):408-15
[PMID] 12167683.
2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Bone marrow transplantation.
28(2):187-96
[PMID] 11509937.
2001
Documenting the case for stem cell transplantation: the role of evidence-based reviews and implications for future research. Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation (ASBMT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
7(6):306-7
[PMID] 11464974.
2001
Empiric antifungal therapy for the neutropenic patient.
Oncology (Williston Park, N.Y.).
15(3):351-63; discussion 363
[PMID] 11301832.
2001
Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
7(8):433-8
[PMID] 11569888.
2001
Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
33(7):947-53
[PMID] 11528564.
2001
Gastroparesis following bone marrow transplantation.
Bone marrow transplantation.
28(1):59-62
[PMID] 11498745.
2001
Infection and mucosal injury in cancer treatment.
Journal of the National Cancer Institute. Monographs.
(29):31-6
[PMID] 11694563.
2001
Infections following hematopoietic stem cell transplantation.
Infectious disease clinics of North America.
15(2):483-520
[PMID] 11447707.
2001
Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?
Bone marrow transplantation.
27(11):1197-200
[PMID] 11551031.
2001
Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab.
Bone marrow transplantation.
27(3):329-32
[PMID] 11277182.
2000
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
31(5):1155-63
[PMID] 11073745.
2000
Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center.
Bone marrow transplantation.
25(6):673-6
[PMID] 10734303.
2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy).
Bone marrow transplantation.
25 Suppl 2:S35-8
[PMID] 10933185.
2000
Approach to invasive fungal infection after blood or marrow transplantation.
Transplantation proceedings.
32(7):1543-4
[PMID] 11119826.
2000
ASBMT policy statement regarding the methodology of evidence-based reviews in evaluating the role of blood and marrow transplantation in the treatment of selected diseases. American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
6(5):524-5
[PMID] 11063382.
2000
Characterization and outcome of “hard to mobilize”‘ lymphoma patients undergoing autologous stem cell transplantation.
Leukemia & lymphoma.
39(5-6):509-19
[PMID] 11342334.
2000
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Medicine.
79(4):250-60
[PMID] 10941354.
2000
Status of high-dose chemotherapy for breast cancer: a review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
6(5):476-95
[PMID] 11063377.
2000
Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents.
Medical mycology.
38(2):169-75
[PMID] 10817234.
1999
Can 40 seconds of compassion reduce patient anxiety?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
17(1):371-9
[PMID] 10458256.
1999
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
29(6):1402-7
[PMID] 10585786.
1999
Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.
Bone marrow transplantation.
23(9):867-73
[PMID] 10338040.
1999
Fungal infections after bone marrow transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
5(2):55-68
[PMID] 10371357.
1999
High-Dose Chemotherapy with Autologous Stem Cell Rescue as a Treatment Modality for Breast Cancer.
The breast journal.
5(5):308-318
[PMID] 11348307.
1999
Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation.
Bone marrow transplantation.
24(12):1323-7
[PMID] 10627642.
1999
Liposomal amphotericin B for fever and neutropenia.
The New England journal of medicine.
341(15):1153; author reply 1154-5
[PMID] 10515753.
1999
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
The New England journal of medicine.
341(1):14-21
[PMID] 10387937.
1999
Musculoskeletal tumors of childhood.
The New England journal of medicine.
341(22):1701-2
[PMID] 10610443.
1999
Opportunistic infections after blood and marrow transplantation.
Transplant infectious disease : an official journal of the Transplantation Society.
1(1):3-20
[PMID] 11428967.
1999
Practical considerations in the use of tacrolimus for allogeneic marrow transplantation.
Bone marrow transplantation.
24(10):1053-6
[PMID] 10578154.
1999
Reintegration after bone marrow transplantation.
Cancer practice.
7(4):190-7
[PMID] 10687584.
1999
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
5(2):94-7
[PMID] 10371361.
1999
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
5(3):180-6
[PMID] 10392964.
1999
Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
Pediatrics.
103(4)
[PMID] 10103336.
1999
Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations.
Blood.
94(5):1833-4
[PMID] 10507843.
1998
Acute oral pain and mucositis in bone marrow transplant and leukemia patients: data from a pilot study.
Cancer nursing.
21(6):385-93
[PMID] 9848996.
1998
An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
6(6):511-7
[PMID] 9833299.
1998
Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
Antimicrobial agents and chemotherapy.
42(12):3103-6
[PMID] 9835498.
1998
Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes.
Cytometry.
34(3):121-7
[PMID] 9696156.
1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood.
92(7):2303-14
[PMID] 9746768.
1998
Quality of life following bone marrow transplantation.
Current opinion in oncology.
10(2):108-11
[PMID] 9555531.
1998
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
27(2):296-302
[PMID] 9709879.
1998
Recent advances in the management of viral infections.
Cancer treatment and research.
96:183-200
[PMID] 9711400.
1998
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
4(3):157-63
[PMID] 9923414.
1998
Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent acute myelogenous leukemia failing autologous peripheral blood progenitor cell transplant: a case history and review.
Bone marrow transplantation.
21(12):1197-200
[PMID] 9674851.
1998
Tacrolimus pharmacokinetics in BMT patients.
Bone marrow transplantation.
21(1):23-8
[PMID] 9486490.
1998
The effect of overnight storage of leukapheresis stem cell products on cell viability, recovery, and cost.
Journal of hematotherapy.
7(5):431-6
[PMID] 9829317.
1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Bone marrow transplantation.
20(3):219-25
[PMID] 9257890.
1997
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
24(4):635-42
[PMID] 9145737.
1997
Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Bone marrow transplantation.
19(4):343-7
[PMID] 9051244.
1997
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Antimicrobial agents and chemotherapy.
41(1):196-9
[PMID] 8980781.
1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
Bone marrow transplantation.
20(1):49-51
[PMID] 9232256.
1997
Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions.
Bone marrow transplantation.
19(2):175-7
[PMID] 9116616.
1997
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
3(1):25-33
[PMID] 9209738.
1997
The true cost of bone marrow transplantation.
The American journal of the medical sciences.
314(2):101-12
[PMID] 9258212.
1996
Association of busulfan area under the curve with veno-occlusive disease following BMT.
Bone marrow transplantation.
17(2):225-30
[PMID] 8640171.
1996
Coping with the physical and psychosocial sequelae of bone marrow transplantation among long-term survivors.
Journal of behavioral medicine.
19(2):163-84
[PMID] 9132508.
1996
Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice.
Blood.
87(8):3237-44
[PMID] 8605339.
1996
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
Transplantation.
61(8):1268-72
[PMID] 8610430.
1996
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Blood.
87(8):3514-9
[PMID] 8605372.
1996
Host immunologic augmentation for the control of infection.
Infectious disease clinics of North America.
10(2):345-64
[PMID] 8803624.
1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
14(4):1156-64
[PMID] 8648370.
1996
Necrotizing cerebritis in an allogeneic bone marrow transplant recipient due to Cladophialophora bantiana.
Journal of clinical microbiology.
34(5):1330-2
[PMID] 8727934.
1996
Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
Bone marrow transplantation.
18(3):569-72
[PMID] 8879619.
1996
Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation.
Hepatology (Baltimore, Md.).
24(3):588-91
[PMID] 8781329.
1995
CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1.
Blood.
86(5):1749-56
[PMID] 7544640.
1995
Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol.
The American journal of medicine.
99(2):164-72
[PMID] 7625421.
1995
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification.
Journal of clinical microbiology.
33(5):1263-6
[PMID] 7615738.
1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Transplantation proceedings.
27(1)
[PMID] 7533383.
1995
Importance of Candida species other than C. albicans as pathogens in oncology patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
20(1):115-25
[PMID] 7727637.
1995
Low incidence of red cell and HLA antibody formation by bone marrow transplant patients.
Transfusion.
35(11):931-5
[PMID] 8604491.
1995
Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
American journal of hematology.
50(3):167-72
[PMID] 7485077.
1995
Re: Severe interaction between methotrexate and a macrolide-like antibiotic.
Journal of the National Cancer Institute.
87(21):1641-2
[PMID] 7563209.
1995
The paranasal sinuses of patients with acute graft-versus-host disease.
AJNR. American journal of neuroradiology.
16(6):1287-91
[PMID] 7677027.
1995
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation.
Bone marrow transplantation.
16(5):715-6
[PMID] 8547871.
1994
Functional ability and quality of life of patients after allogeneic bone marrow transplantation.
Bone marrow transplantation.
14 Suppl 4:S29-33
[PMID] 7728121.
1994
Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
19 Suppl 1:S49-53
[PMID] 7948571.
1994
Predictors of acute respiratory failure after bone marrow transplantation in children.
Critical care medicine.
22(9):1485-91
[PMID] 8062574.
1994
Quality of life of bone marrow transplant long-term survivors.
Bone marrow transplantation.
13(5):589-96
[PMID] 8054912.
1994
Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
The New England journal of medicine.
331(5):330; author reply 330-1
[PMID] 8022452.
1994
Viral infections in severely immunocompromised cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2(6):355-68
[PMID] 7858927.
1993
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Antimicrobial agents and chemotherapy.
37(9):1847-9
[PMID] 8239594.
1993
Bone marrow transplantation and cataract development.
Archives of ophthalmology (Chicago, Ill. : 1960).
111(10):1367-73
[PMID] 8216017.
1993
Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Cancer genetics and cytogenetics.
65(2):135-40
[PMID] 8453599.
1993
Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
Bone marrow transplantation.
12(3):273-82
[PMID] 8241987.
1993
Factors influencing third party payer costs for allogeneic BMT.
Bone marrow transplantation.
12(1):43-8
[PMID] 8397032.
1993
Infections in allogeneic bone marrow transplant recipients.
Seminars in oncology.
20(5 Suppl 6):80-7
[PMID] 8211220.
1993
New preparative regimens with diaziquone or cytarabine in combination with busulfan and cyclophosphamide.
Seminars in oncology.
20(4 Suppl 4):56-63; quiz 64
[PMID] 8342077.
1993
Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation.
Oncology nursing forum.
20(10):1493-502
[PMID] 8278277.
1993
Personal changes, dispositional optimism, and psychological adjustment to bone marrow transplantation.
Journal of behavioral medicine.
16(5):423-43
[PMID] 8254649.
1993
Viral infections in leukemia and bone marrow transplant patients.
Leukemia & lymphoma.
11 Suppl 2:115-25
[PMID] 8124223.
1992
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
10(5):779-89
[PMID] 1569450.
1992
Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation.
Blood.
79(4):1068-73
[PMID] 1737091.
1992
Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice.
Bone marrow transplantation.
9(3):199-204
[PMID] 1354995.
1992
Sexual satisfaction in survivors of bone marrow transplantation.
Bone marrow transplantation.
9(3):185-90
[PMID] 1511256.
1992
Thalidomide for the treatment of chronic graft-versus-host disease.
The New England journal of medicine.
326(16):1055-8
[PMID] 1549151.
1992
The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
Leukemia & lymphoma.
8(4-5):353-9
[PMID] 1290959.
1991
Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Bone marrow transplantation.
7(3):183-91
[PMID] 2059755.
1991
Health, functional status, and employment of adult survivors of bone marrow transplantation.
Annals of internal medicine.
114(2):113-8
[PMID] 1984385.
1991
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
The New England journal of medicine.
325(18):1274-7
[PMID] 1669837.
1991
Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity.
Ophthalmology.
98(8):1294-301
[PMID] 1923369.
1991
Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive disease.
Oral surgery, oral medicine, and oral pathology.
72(4):419-24
[PMID] 1923439.
1991
PUVA therapy for chronic cutaneous graft-vs-host disease.
Archives of dermatology.
127(11):1673-8
[PMID] 1952971.
1991
Role retention and quality of life of bone marrow transplant survivors.
Social science & medicine (1982).
32(6):697-704
[PMID] 2035046.
1990
Advances in the management of infectious complications after bone marrow transplantation.
Bone marrow transplantation.
6(6):371-83
[PMID] 2129021.
1990
Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
8(5):820-30
[PMID] 2332770.
1990
Coaggregation of oral Candida isolates with bacteria from bone marrow transplant recipients.
Journal of clinical microbiology.
28(12):2621-6
[PMID] 2279992.
1990
Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy.
Reviews of infectious diseases.
12 Suppl 7:S793-804
[PMID] 2173108.
1990
Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.
Cancer investigation.
8(5):509-21
[PMID] 2176125.
1990
Management of infectious complications of bone marrow transplantation.
Oncology (Williston Park, N.Y.).
4(2):69-75; discussion 76, 81
[PMID] 2143670.
1990
Oral complications of cancer therapies. Infectious and noninfectious systemic consequences.
NCI monographs : a publication of the National Cancer Institute.
(9):21-6
[PMID] 2188156.
1990
Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation.
Gastroenterology.
99(2):536-8
[PMID] 2365200.
1989
Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia.
Blood.
73(8):2209-18
[PMID] 2659102.
1989
Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
Bone marrow transplantation.
4(6):685-9
[PMID] 2819287.
1989
Cutaneous graft-versus-host reaction lacks evidence of cutaneous cytomegalovirus by the immunoperoxidase technique.
The Journal of investigative dermatology.
93(1):92-5
[PMID] 2545790.
1989
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
Blood.
74(1):501-6
[PMID] 2665843.
1989
Herpes zoster infection after autologous bone marrow transplantation.
Blood.
74(4):1424-7
[PMID] 2548641.
1989
Longitudinal changes in pulmonary function following bone marrow transplantation.
Chest.
96(2):301-6
[PMID] 2666044.
1989
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation.
Blood.
74(4):1428-35
[PMID] 2670000.
1989
The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease.
Archives of ophthalmology (Chicago, Ill. : 1960).
107(9):1343-8
[PMID] 2675805.
1988
Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG.
Blood.
72(2):621-7
[PMID] 3042044.
1988
Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation.
Blood.
71(5):1432-7
[PMID] 2833959.
1988
Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.
Medicine.
67(3):175-86
[PMID] 2835573.
1988
Interstitial pneumonitis following autologous bone marrow transplantation.
Transplantation.
46(1):61-5
[PMID] 2839915.
1988
Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin’s disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
6(10):1558-61
[PMID] 3049950.
1987
Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas–Baltimore experiences.
Acta haematologica.
78 Suppl 1:175-80
[PMID] 3124443.
1987
Aspergillus infections in bone marrow transplant recipients.
Bone marrow transplantation.
2(2):175-81
[PMID] 3332165.
1987
Differences between first and subsequent fevers during prolonged neutropenia.
Cancer.
59(4):844-9
[PMID] 3542189.
1987
Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole.
The American journal of medicine.
83(6):1103-10
[PMID] 3332568.
1986
Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.
Antimicrobial agents and chemotherapy.
30(3):435-9
[PMID] 3640591.
1985
Detection of Epstein-Barr virus DNA in mouthwashes by hybridization.
Journal of clinical microbiology.
21(3):353-6
[PMID] 2984244.
1985
Late-onset interstitial pneumonia following allogeneic bone marrow transplantation.
Transplantation.
39(1):21-3
[PMID] 2981443.
1983
Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation.
Antimicrobial agents and chemotherapy.
23(4):593-7
[PMID] 6305264.
1982
Acyclovir in mouse cytomegalovirus infections.
The American journal of medicine.
73(1A):118-24
[PMID] 6285701.
1982
Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice.
Infection and immunity.
37(2):833-6
[PMID] 6749689.
1981
Efficacy of acyclovir against mouse cytomegalovirus in vivo.
Antimicrobial agents and chemotherapy.
20(2):275-8
[PMID] 6269490.
1980
The value of fungal surveillance cultures as predictors of systemic fungal infections.
The Journal of infectious diseases.
142(4):503-9
[PMID] 7192301.
1979
Candida tropicalis: a major pathogen in immunocompromised patients.
Annals of internal medicine.
91(4):539-43
[PMID] 384857.
Grants
Jul 2021
– Jun 2023
The Role of the Gut Microbiome in Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia
Role: Principal Investigator
Funding: AMER SOC OF HEMATOLOGY
May 2019
– Jul 2023
Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation (CHARM)
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
Sep 2018
– Jul 2021
Developing the Biobehavioral Foundation for Self-Management of Psychoneurological Symptoms in Hematopoietic Cell Transplant (HCT) Survivors
Role: Co-Investigator
Funding: NATL INST OF HLTH NINR
Jan 2018
– Mar 2023
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3-ITD AML
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via ASTELLAS PHARMA US
Oct 2017
– Oct 2022
Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (CHAMP)
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Aug 2017
– Feb 2025
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete R
Role: Project Manager
Funding: NRG ONCOLOGY FOU
via NATL INST OF HLTH NCI
Jul 2017
– Jun 2024
Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network
Role: Project Manager
Funding: NATL INST OF HLTH NHLBI
Jun 2017
– May 2021
DRPD-R0F2017: An Integrated Multi-'omics' Analysis of Myelodysplastic Syndromes
Role: Co-Investigator
Funding: UF DSR OPPORTUNITY FUND
Mar 2017
– Jan 2021
Miscellaneous Donors Project
Role: Principal Investigator
Funding: MISCELLANEOUS DONORS
Sep 2016
– Sep 2021
A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients with Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NCI
Jul 2016
– Jun 2021
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NCI
Oct 2015
– May 2017
A Randomized Recruitment Intervention Trial
Role: Principal Investigator
Funding: UNIV OF TEXAS HLTH SCI CTR AT HOUSTON
via NATL INST OF HLTH NIMHD
Sep 2015
– Dec 2022
Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
May 2015
– May 2018
Randomized study of individualized care plans
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via PATIENT-CENTERED OUTCOMES RES INST
May 2015
– Apr 2016
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
Apr 2015
– Apr 2023
A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
Jul 2014
– Jun 2019
A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls, BMT CTN PROTOCOL #1203
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
May 2014
– May 2019
CTN1102: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
Sep 2013
– Sep 2016
Individualized Care Plans for Hematopoietic Cell Transplant Services
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via PATIENT-CENTERED OUTCOMES RES INST
Jul 2013
– Dec 2019
Re-MATCH: Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive Cell Therapy During Recovery from Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation
Role: Project Manager
Funding: US ARMY MED RES ACQUISITION
May 2013
– Apr 2020
Protocol 1202: Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
Aug 2012
– Jul 2016
Phase II Study of Combination of Hyper-CVAD and Dasatinib with orwithout allogeneic stem cell transplant in Patients with Philadelphia (Ph)Chromosome Positive and/or Bcr-Abl Positive Acute LymphoblasticLeukemia (ALL) (A BMT Study)."
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
Apr 2012
– Dec 2022
A Multi-Center, Phase III, Randomized A Multi-Center, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood(dUCB) vesus HLA-Haploidentical
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
Mar 2012
– Aug 2020
UFRCC for Cardiovascular Cell Therapy Research Network
Role: Co-Investigator
Funding: NATL INST OF HLTH NHLBI
Dec 2011
– Aug 2021
CLINICAL TRIAL OPERATING ACCOUNT
Role: Principal Investigator
Funding: 214 OPERATING ACCOUNT
Aug 2011
– Jun 2017
Core Clinical Consortium for Blood & Marrow Transplant Clinical Trials Network
Role: Principal Investigator
Funding: NATL INST OF HLTH NHLBI
Dec 2010
– Dec 2019
Protocol 0804: A Phase II study of reduced-intensity allogeneic stem cell transplant for high risk chronic lymphocytic leukemia
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Dec 2010
– Apr 2016
Protocol 0901: A Randomized, Multi-Center, Phase III Study Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
Oct 2010
– Oct 2017
F014160: Support Teaching and Research Programs at UF Shands Cancer Center
Role: Principal Investigator
Funding: UF FOUNDATION
Sep 2010
– Aug 2016
Protocol 0803: High Dose Chemotherapy with Autologous Stem Cell Rescue For Aggressive B Cell
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Jul 2010
– Jun 2019
F002418: Support ESC devoted to Cancer Research, Teaching and Patient Care
Role: Principal Investigator
Funding: UF FOUNDATION
Apr 2010
– Apr 2016
Protocol #0702A Trial of Single AutologousTransplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for patients with Multiple zmyelonma BMT CTN
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Feb 2010
– Feb 2022
A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-vers
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
Feb 2010
– Feb 2016
A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteriods with Placebo as Initial Systemic Treatment of Acute GVHD
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
May 2008
– May 2017
Protocol #0703: A Phase II Study of Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin's Disease
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH NHLBI
Jul 2007
– Jun 2019
Umbilical Cord Research
Role: Principal Investigator
Funding: UF FOUNDATION
May 2007
– Feb 2016
Clinical Laboratory Diagnostics for Invasive Aspergillosis
Role: Principal Investigator
Funding: NATL INST OF HLTH NIAID
Feb 2007
– Feb 2019
Protocol 0502: A Phase II Study of Allogenic Transplant for Older Patients w/ AML in First Morphologic Complete Remission Using a Non-Myeloblative Preparation Regimen
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Feb 2007
– Feb 2016
A Phase III Randomized, Mutlicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (Protocol 0402)
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Feb 2007
– Feb 2016
Protocol 0501: Multi-center, Open Label, Randomized Trial Comparing Single versus Double Umbilical Corb (UCB) Transplantation in Pediatric Patients w. high Risk Leukemia and Myelodysplasia
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Dec 2006
– Dec 2015
Protocol #0401: Phase III Rituxan/BEAM vs. Bexxar/BEAM
Role: Principal Investigator
Funding: NATL MARROW DONOR PROG dba NMDP
via NATL INST OF HLTH
Education
Fellowship – Oncology
1979
·
Johns Hopkins University
Residency – Internal Medicine
1977
·
Regional Medical Center
Internship – Internal Medicine
1974
·
Regional Medical Center
Medical Degree
1973
·
Johns Hopkins University
Contact Details
Phones:
- Business:
- (352) 256-4033
Emails:
- Business:
- wingajr@ufl.edu
Addresses:
- Business Mailing:
-
1600 SW ARCHER ROAD
1600 SW ARCHER RD
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
GAINESVILLE FL 326103003 - Business Street:
-
2033 MOWRY ROAD
2033 MOWRY ROAD ROOM 141
CANCER GENETICS RESEARCH COMPLEX
GAINESVILLE FL 326100001